CITALOPRAM HYDROBROMIDE

Generic: CITALOPRAM HYDROBROMIDE

Aurobindo Pharma LimitedManufacturer
ORALRoute
CITALOPRAM HYDROBROMIDEActive Substance
2006-08-28Original Approval

CITALOPRAM HYDROBROMIDE is FDA application ANDA077812, sponsored by AUROBINDO PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2022-01-26
CITALOPRAM Tablets, USP, 20MG, 100 Tablets, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage condi

Top Reported Reactions

1
FATIGUE
6,990 reports
2
NAUSEA
6,018 reports
3
DRUG INEFFECTIVE
5,544 reports
4
HEADACHE
5,146 reports
5
TOXICITY TO VARIOUS AGENTS
5,099 reports
6
DIARRHOEA
4,831 reports
7
FALL
4,460 reports
8
DIZZINESS
4,425 reports
9
PAIN
4,424 reports
10
OFF LABEL USE
4,363 reports